Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smidge is a premium nutraceutical company that specializes in high-quality, small-batch supplements designed for individuals with sensitive digestive systems. Originally founded as GutPro, the company rebranded to Smidge to reflect its focus on clean, additive-free formulations that support gut health and the microbiome. Their product portfolio includes specialized probiotics, digestive enzymes, and bioavailable vitamins such as Kakadu Plum and Oysterzinc. Smidge emphasizes purity by excluding common allergens, fillers, and synthetic ingredients from its manufacturing process. The company serves a niche market of health-conscious consumers and practitioners focused on therapeutic nutrition and gut-brain health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smidge.